Literature DB >> 20224493

Breast cancer: risk assessment and prevention.

Mary A Hooks1.   

Abstract

Breast cancer is the most common cancer and the second most common cause of cancer death in women. In 2008 there were 182,460 women diagnosed with breast cancer, and 40,480 women died of this disease. Breast cancer can be prevented by medical (tamoxifen or raloxifene) or surgical approaches (bilateral mastectomy or oophorectomy). Prevention is only recommended for women at high risk for developing breast cancer; therefore, proper risk calculation is essential in identifying women that may benefit from prevention measures. There is an easy-to-use and easily accessible risk calculation tool for determining a woman's risk of developing breast cancer and need for referral for counseling, gene testing, and possibly preventive therapy. This article reviews the components of risk assessment, the most frequently used risk calculation tool, and approaches to breast cancer risk reduction including medical and surgical therapies. The use of these therapies results in a risk reduction of 50-90%.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224493     DOI: 10.1097/SMJ.0b013e3181d39038

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  CaliForest: Calibrated Random Forest for Health Data.

Authors:  Yubin Park; Joyce C Ho
Journal:  Proc ACM Conf Health Inference Learn (2020)       Date:  2020-04-02

2.  Exploration of the postponing mechanism that delays carcinoma onset.

Authors:  Chao-Nan Qian
Journal:  Cancer Cell Int       Date:  2010-10-22       Impact factor: 5.722

3.  Calibrating predictive model estimates to support personalized medicine.

Authors:  Xiaoqian Jiang; Melanie Osl; Jihoon Kim; Lucila Ohno-Machado
Journal:  J Am Med Inform Assoc       Date:  2011-10-07       Impact factor: 4.497

4.  The use of magnetic resonance mammography in women at increased risk for developing breast cancer.

Authors:  Tadeusz J Popiela; Wojciech Kibil; Izabela Herman-Sucharska; Andrzej Urbanik
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-10-30       Impact factor: 1.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.